2015•China Foreign Medical TreatmentRequires access

Drug therapy combined with diet control clinical therapeutic effect in the treatment of ulcerative colitis

MA Yongfan

Open publisher page 0 citations

Abstract

Objective Analysis and Discussion on treatment combined with diet control for treatment of the clinical effect and safety of drug use in patients with ulcerative colitis. Methods Selected 68 cases of ulcerative colitis were randomly divided into experimental group(by the Mesalamine combined with diet control therapy) and control group(give simple Mesalamine treating),comparative observation of the clinical efficacy of the two groups. Results The experimental group total effective rate(91.1%) was significantly higher than that of the control group(73.5%),compared with statistically significant difference(P0.05);the patients in the two groups after treatment CRP and IL-8 index were significantly lower than those before treatment(P0.05),While the IL-10 index levels significantly after treatment(P0.05),But the contrast between the two groups,The experimental group improved more significantly(P0.05). The incidence of adverse reactions and the patients in the experimental group(11.8%) was significantly lower than the control group(29.4%), statistically significant difference comparison(P0.05). Conclusion Ulcerative colitis patients clinical effect by Mesalamine combined with diet control therapy significantly, Worth promoting. It is worthy of further promotion in clinical.

About this research paper

What this paper is about

Objective Analysis and Discussion on treatment combined with diet control for treatment of the clinical effect and safety of drug use in patients with ulcerative colitis. Methods Selected 68 cases of ulcerative colitis were randomly divided into experimental group(by the Mesalamine combined with diet control therapy) and control group(give simple Mesalamine treating),comparative observation of the clinical efficacy of the two groups. Results The experimental group total effective rate(91.1%) was significantly higher than that of the control group(73.5%),compared with statistically significant difference(P0.05);the patients in the two groups after treatment CRP and IL-8 index were significantly lower than those before treatment(P0.05),While the IL-10 index levels significantly after treatment(P0.05),But the contrast between the two groups,The experimental group improved more significantly(P0.05). The incidence of adverse reactions and the patients in the experimental group(11.8%) was significantly lower than the control group(29.4%), statistically significant difference comparison(P0.05). Conclusion Ulcerative colitis patients clinical effect by Mesalamine combined with diet control therapy significantly, Worth promoting. It is worthy of further promotion in clinical.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective Analysis and Discussion on treatment combined with diet control for treatment of the clinical effect and safety of drug use in patients with ulcerative colitis. Methods Selected 68 cases of ulcerative colitis were randomly divided into experimental group(by the Mesalamine combined with diet control therapy) and control group(give simple Mesalamine treating),comparative observation of the clinical efficacy of the two groups. Results The experimental group total effective rate(91.1%) was significantly higher than that of the control group(73.5%),compared with statistically significant difference(P0.05);the patients in the two groups after treatment CRP and IL-8 index were significantly lower than those before treatment(P0.05),While the IL-10 index levels significantly after treatment(P0.05),But the contrast between the two groups,The experimental group improved more significantly(P0.05). The incidence of adverse reactions and the patients in the experimental group(11.8%) was significantly lower than the control group(29.4%), statistically significant difference comparison(P0.05). Conclusion Ulcerative colitis patients clinical effect by Mesalamine combined with diet control therapy significantly, Worth promoting. It is worthy of further promotion in clinical.

Key concepts: Medicine, Ulcerative colitis, Internal medicine, Gastroenterology, Therapeutic effect, Incidence (geometry), Colitis, Clinical efficacy

Related papers

Back to paper searchBrowse research topicsOriginal source
Drug therapy combined with diet control clinical therapeutic effect in the treatment of ulcerative colitis — Research Paper | ScholarLens